...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: While we are waiting ...

Given that we will have numbers on secondary indications at Bio Europe I'll go with CAD $63 on the TSX on 15 Sept 2019, assuming that's a trading day.


New Message
Please login to post a reply